NCT01775111

Brief Summary

The aim of this randomized, observer-blind, controlled intervention study with parallel groups is to study the effect of strength training (2x/week for 6 months) with and without additional dietary supplementation (protein-enriched) on muscle strength, function and mass, oxidative stress parameters and the immune system in elderly institutionalized persons. The participants (n = 120) are recruited from Viennese senior residencies (Kuratorium Wiener Pensionistenwohnheime). After a pre-participation screening participants will be distributed randomly but stratified by sex and age to one of the 3 intervention groups (cognitive training, strength training, strength training + supplement). Study participants are eligible if they are male or female with an age over 65 years and if their cognitive status as well as their physical fitness level allows to participate at the strength training sessions. Exclusion criteria comprise chronic diseases which contraindicate the medical training therapy, serious cardiovascular disease, diabetic retinopathy and manifest osteoporosis, medication with anticoagulants or cortisone drugs and also regular strength training during the last six months. Primary outcome measure is the change in isokinetic torque of knee extensors. Secondary outcome measures comprise anthropometric data, functional performance tests, immunological and oxidative stress parameters. The change in muscle signaling pathways will be assessed from muscle biopsies.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 21, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 24, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Last Updated

January 24, 2013

Status Verified

January 1, 2013

Enrollment Period

1.9 years

First QC Date

January 21, 2013

Last Update Submit

January 21, 2013

Conditions

Keywords

strength trainingprotein supplementationsarcopenia

Outcome Measures

Primary Outcomes (1)

  • change from baseline in isokinetic torque of knee extensors

    baseline and 6 months

Secondary Outcomes (7)

  • change from baseline in 6min walking test

    baseline and 6 months

  • change from baseline in handgrip strength

    baseline and 6 months

  • change from baseline in single leg balance stand

    baseline and 6 months

  • change from baseline in lean body mass

    baseline and 6 months

  • change from baseline in muscular myostatin expression

    baseline and 6 months

  • +2 more secondary outcomes

Other Outcomes (2)

  • change from baseline in isokinetic torque of knee extensors at 12 months

    baseline and 12 months

  • change from baseline in isokinetic torque of knee extensors at 18 months

    baseline and 18 months

Study Arms (3)

Cognitive Training

SHAM COMPARATOR

Cognitive Training (riddles, skill games, ...) is performed twice a week in small groups

Behavioral: Cognitive Training

Strength Training

EXPERIMENTAL

Progressive strength training is applied, meaning that the intensity is adjusted continuously in order to obtain a sufficient training stimulus. Exercises are chosen to involve the major muscle groups and are performed by using the own body weight or elastic bands.

Behavioral: Strength Training

Strength Training and Supplement

EXPERIMENTAL

In addition to strength training as described above, participants receive a water-soluble dietary supplement 9x/week (FortiFit, Nutricia) consisting of 20.7 g of protein (56 En%, 19.7 g whey protein, 3 g leucine,\> 10 g essential amino acids), 9.3 g carbohydrates (25 En%, 0.8 BE), 3.0 g fat (18 En%), 1.2 g fiber (2 En%), 800 IU (20μg) of vitamin D, 250mg calcium, vitamins B6 and B12, folic acid and magnesium.

Behavioral: Strength TrainingDietary Supplement: FortiFit

Interventions

Cognitive Training
Strength TrainingStrength Training and Supplement
FortiFitDIETARY_SUPPLEMENT
Strength Training and Supplement

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Adequate mental condition in order to follow the instructions and to perform the resistance exercise independently (Mini-Mental-State \>23)
  • Ability to walk 10 meters independently (without orthopaedic devices)
  • or more points at the Short Physical Performance Battery

You may not qualify if:

  • Chronic diseases, which contraindicate a medical training therapy
  • Serious cardiovascular diseases (congestive chronic heart failure, severe or symptomatic aortic stenosis, unstable angina pectoris, untreated arterial hypertension, cardiac arrhythmias)
  • Diabetic retinopathy
  • Manifest osteoporosis
  • Regular use of cortisone-containing drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Vienna, Centre of Sports Science and University Sports

Vienna, Vienna, 1150, Austria

RECRUITING

Related Publications (3)

  • Franzke B, Schober-Halper B, Hofmann M, Oesen S, Tosevska A, Henriksen T, Poulsen HE, Strasser EM, Wessner B, Wagner KH. Age and the effect of exercise, nutrition and cognitive training on oxidative stress - The Vienna Active Aging Study (VAAS), a randomized controlled trial. Free Radic Biol Med. 2018 Jun;121:69-77. doi: 10.1016/j.freeradbiomed.2018.04.565. Epub 2018 Apr 24.

  • Tosevska A, Franzke B, Hofmann M, Vierheilig I, Schober-Halper B, Oesen S, Neubauer O, Wessner B, Wagner KH. Circulating cell-free DNA, telomere length and bilirubin in the Vienna Active Ageing Study: exploratory analysis of a randomized, controlled trial. Sci Rep. 2016 Dec 1;6:38084. doi: 10.1038/srep38084.

  • Grimpampi E, Oesen S, Halper B, Hofmann M, Wessner B, Mazza C. Reliability of gait variability assessment in older individuals during a six-minute walk test. J Biomech. 2015 Nov 26;48(15):4185-4189. doi: 10.1016/j.jbiomech.2015.10.008. Epub 2015 Oct 20.

MeSH Terms

Conditions

Sarcopenia

Interventions

Cognitive TrainingResistance Training

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesExercise TherapyPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Barbara Wessner, Ass.-Prof. DI Dr.

    University of Vienna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael Quittan, Prim. Univ.Prof. Dr.

CONTACT

Barbara Wessner, Ass.-Prof. DI Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ass.Prof. DI Dr.

Study Record Dates

First Submitted

January 21, 2013

First Posted

January 24, 2013

Study Start

January 1, 2012

Primary Completion

December 1, 2013

Last Updated

January 24, 2013

Record last verified: 2013-01

Locations